Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Safety and Efficacy of MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Combination With Low-Dose CsA, Tac or Sir in Comparison to Current Standard Immunosuppression (MMF, CsA and Corticosteroids) in Renal Tx

NCT00231764 is registered in ClinicalTrials.gov with Ekberg, Henrik, M.D. as lead sponsor.

NCT NCT00231764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00231764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Safety and Efficacy of MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Combination With Low-Dose CsA, Tac or Sir in Comparison to Current Standard Immunosuppression (MMF, CsA and Corticosteroids) in Renal Tx
Lead sponsor
Ekberg, Henrik, M.D.
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2002
Completion date
February 29, 2008
Enrollment
1,760
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation